Blood group and response to high dose IgG

Systemic Irradiation Therapy of Myelomatosis-The Therapeutic Implications of Technique.

Leukemia & lymphoma·2016

The Management of Relapsed and Refractory Acute Myeloid Leukaemia in Adults.

Leukemia & lymphoma·2016

A Pilot Study Using Intravenous Immunoglobulin for the Prevention of Infection During Remission Induction in Acute Leukaemia.

Leukemia & lymphoma·2016

Non-inpatient Treatment of Febrile Episodes in Patients with Hematological Malignancy.

Hematology (Amsterdam, Netherlands)·2016

Interleukin-3: Promises and Perspectives.

Hematology (Amsterdam, Netherlands)·2016

Clinical Regression and Remission of Primary Refractory Angiocentric Lymphoma Following Autologous Tumour Peptide Antigen-charged Dendritic Cells After High-dose Chemotherapy and Autologous Stem Cell Rescue.

Hematology (Amsterdam, Netherlands)·2016

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Lancet (London, England)·2026

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Mechanisms of antibody-mediated enhancement of immune responses.

The Journal of experimental medicine·2026

A predictive multiscale framework for post-translational modification-dependent peptide-MHC class I binding.

Physical chemistry chemical physics : PCCP·2026

Persistently Elevated Serum IgM: A Diagnostic Red Flag for Primary Immunodeficiencies: A Case-Based Review and Clinical Approach.

Endocrine, metabolic & immune disorders drug targets·2026

Extended routine lymphocyte immunophenotyping refines individual immune organization across a heterogeneous patient cohort.

Cytometry. Part B, Clinical cytometry·2026

A prospective study on the safety and clinical effectiveness of rabies monoclonal antibodies for post exposure prophylaxis in suspected rabies exposures at the anti-rabies clinic of KIMS Hospital and Research Centre, Bangalore.

Clinical and experimental vaccine research·2026

Lung ultrasound and the interstitial syndrome in tuberculosis endemic regions: illustrated insights from diverse clinical settings.

Journal of clinical tuberculosis and other mycobacterial diseases·2026

Related Experiment Videos

Blood group and response to high dose IgG

Related Concept Videos

Systemic Irradiation Therapy of Myelomatosis-The Therapeutic Implications of Technique.

The Management of Relapsed and Refractory Acute Myeloid Leukaemia in Adults.

A Pilot Study Using Intravenous Immunoglobulin for the Prevention of Infection During Remission Induction in Acute Leukaemia.

Non-inpatient Treatment of Febrile Episodes in Patients with Hematological Malignancy.

Interleukin-3: Promises and Perspectives.

Clinical Regression and Remission of Primary Refractory Angiocentric Lymphoma Following Autologous Tumour Peptide Antigen-charged Dendritic Cells After High-dose Chemotherapy and Autologous Stem Cell Rescue.

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Mechanisms of antibody-mediated enhancement of immune responses.

A predictive multiscale framework for post-translational modification-dependent peptide-MHC class I binding.

Persistently Elevated Serum IgM: A Diagnostic Red Flag for Primary Immunodeficiencies: A Case-Based Review and Clinical Approach.

Extended routine lymphocyte immunophenotyping refines individual immune organization across a heterogeneous patient cohort.

A prospective study on the safety and clinical effectiveness of rabies monoclonal antibodies for post exposure prophylaxis in suspected rabies exposures at the anti-rabies clinic of KIMS Hospital and Research Centre, Bangalore.

Lung ultrasound and the interstitial syndrome in tuberculosis endemic regions: illustrated insights from diverse clinical settings.

Related Experiment Videos

Blood group and response to high dose IgG

Related Concept Videos

Related Articles